Free tool
Rare disease stocks
We cover 1 company grouped under the Rare disease theme. The median market value in the group is $3.79B. Across the group, the median move over the past trading day is +0.90%. Price change over the past year runs from −15.3% to −15.3% across the middle 80 percent of the group, with a median of −15.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
1 company of 268 matches these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| CAMX.ST | Camurus AB (publ) | $3.79B | Mid cap | −15.35% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.